ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,020Medicare Part D Prescriptions Filled, Including Refills

Rank: 195 out of 676

$435K Total Retail Price of All Prescriptions

Rank: 255 out of 676

437 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 7,498 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 605 261 S3 1 1
OMEPRAZOLE 506 311 2 2
LISINOPRIL 479 340 3 5
AMLODIPINE BESYLATE 412 310 4 3
FUROSEMIDE 286 217 5 4
LOVASTATIN 247 159 6 33
LEVOTHYROXINE SODIUM 221 197 7 7
MELOXICAM 207 123 8 13
SERTRALINE HCL 203 87 9 26
METFORMIN HCL 197 111 10 8
AZITHROMYCIN 193 125 11 39
CITALOPRAM HBR 171 126 12 17
ZOLPIDEM TARTRATE 165 104 13 21
DIOVAN 145 102 14 37
NAPROXEN 144 95 15 71
WARFARIN SODIUM 142 126 16 18
GABAPENTIN 141 104 17 10
NEXIUM 139 94 18 23
METOPROLOL TARTRATE 125 89 19 22
TRAMADOL HCL 124 81 20 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 86 21 16
CIPROFLOXACIN HCL 120 87 22 45
SIMVASTATIN 119 93 23 6
ALLOPURINOL 114 85 24 31
HYDROCHLOROTHIAZIDE 114 87 24 12
GLIMEPIRIDE 112 96 26 30
CLONIDINE HCL 100 70 27 32
PLAVIX 94 89 28 40
CRESTOR 90 64 29 29
ATORVASTATIN CALCIUM 90 84 29 20
METOPROLOL SUCCINATE 86 66 31 14
CLOPIDOGREL 84 82 32 28
POTASSIUM CHLORIDE 82 45 33 9
ESTRADIOL 80 61 R 34 109
AMITRIPTYLINE HCL 74 59 R 35 46
METHOCARBAMOL 73 17 R 36 163
RANITIDINE HCL 73 36 36 27
AMLODIPINE BESYLATE-BENAZEPRIL 72 55 38 44
FLUTICASONE PROPIONATE 67 37 39 49
CARVEDILOL 67 51 39 15
ALENDRONATE SODIUM 65 65 41 61
TRIAMTERENE-HCTZ 62 62 42 43
LEVOFLOXACIN 61 45 43 91
TAMSULOSIN HCL 61 41 43 38
KLOR-CON M20 61 32 43 67
BENAZEPRIL HCL 60 34 46 58
CARISOPRODOL 59 0 R 47 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 45 47 74
LOSARTAN-HYDROCHLOROTHIAZIDE 58 42 49 51
LOSARTAN POTASSIUM 58 46 49 34
ATENOLOL 57 31 51 25
DILTIAZEM HCL 50 0 52 227
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.